AquaBounty Technologies (NASDAQ:AQB) Posts Quarterly Earnings Results, Meets Estimates

AquaBounty Technologies (NASDAQ:AQB) released its quarterly earnings results on Tuesday. The company reported ($0.88) earnings per share for the quarter, meeting the consensus estimate of ($0.88), RTT News reports. The company had revenue of $0.05 million for the quarter, compared to analyst estimates of $0.10 million. AquaBounty Technologies had a negative return on equity of 17.81% and a negative net margin of 3,923.57%. During the same period in the previous year, the company posted ($1.60) earnings per share.

AquaBounty Technologies Stock Down 2.6 %

Shares of AQB stock traded down $0.03 during mid-day trading on Wednesday, reaching $1.12. 12,348 shares of the company’s stock traded hands, compared to its average volume of 24,268. The company has a quick ratio of 1.96, a current ratio of 1.96 and a debt-to-equity ratio of 0.05. The company’s 50-day moving average price is $1.13 and its 200-day moving average price is $1.47. The company has a market cap of $4.33 million, a P/E ratio of -0.06 and a beta of 1.15. AquaBounty Technologies has a 12 month low of $0.81 and a 12 month high of $4.03.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.